Evidence map›Paper›PMID 28709162›Full record

ArticleThe Pediatric infectious disease journal2017

Late-onset Sepsis in Extremely Premature Infants: 2000-2011.

Rachel G Greenberg, Sarah Kandefer, Barbara T Do, P Brian Smith, Barbara J Stoll, Edward F Bell, Waldemar A Carlo, Abbot R Laptook, Pablo J Sánchez, Seetha Shankaran and 8 more

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 2 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 2 syntheses or guidelines pooled it, 174 citations in OpenAlex.

  1. Antifungal therapy for newborn infants with invasive fungal infection.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Pooled it
  3. Acute kidney injury and subsequent risk of late-onset infection among extremely low gestational age newborns.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Trial
  4. Trial
  5. Trial
  6. Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.Antimicrobial agents and chemotherapy · 2019
    Trial
  7. Mupirocin forPediatrics · 2019
    Trial
  8. Article
  9. Late-Onset Meningitis due toClinical case reports · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Bacterial and fungal infections in infants born before 24 weeks' gestation: a review.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Trends in sex differences in neurodevelopmental outcomes among extremely preterm infants.Archives of disease in childhood. Fetal and neonatal edition · 2025
    Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Rachel G GreenbergFrom the *Department of Pediatrics, Duke University School of Medicine, †Duke Clinical Research Institute, Duke University School of Medicine, and ‡Social, Statistical and Environmental Sciences Unit, RTI International, Research Triangle Park, Durham, North Carolina; §Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia; ¶Department of Pediatrics, University of Iowa, Iowa City, Iowa; ‖Division of Neonatology, University of Alabama at Birmingham, Birmingham, Alabama; **Department of Pediatrics, Women & Infants Hospital, Brown University, Providence, Rhode Island; ††Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas; ‡‡Department of Pediatrics, Wayne State University, Detroit, Michigan; §§Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Lucile Packard Children's Hospital, Palo Alto, California; ¶¶Department of Pediatrics, Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, Ohio; ‖‖Social, Statistical and Environmental Sciences Unit, RTI International, Rockville, Maryland; and ***Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Sarah Kandefer
Barbara T Do
P Brian Smith
Barbara J Stoll
Edward F Bell
Waldemar A Carlo
Abbot R Laptook
Pablo J Sánchez
Seetha Shankaran
Krisa P Van Meurs
M Bethany Ball
Ellen C Hale
Nancy S Newman
Abhik Das
Rosemary D Higgins
C Michael Cotten
Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
RTI International · USLucile Packard Children's Hospital · USDuke University · USDuke University Hospital · USNational Institutes of Health · USUniversity of Iowa · US

Funding

Duke CTSA (Composite)UL1TR001117 · NCATS · DUKE UNIVERSITY · PI BOULWARE, LEIGH E, LI, JENNIFER S · 2013 to 2017
$41.3M
Increasing the Quality and Efficiency of Clinical Trials (R18)R18FD005292 · FDA · DUKE UNIVERSITY · PI LI, JENNIFER S · 2014 to 2019
$26.8M
NICHD Cooperative Multicenter Neonatal Research NetworkU10HD040492 · NICHD · DUKE UNIVERSITY · PI COTTEN, CHARLES MICHAEL · 2001 to 2015
$5.4M
North Carolina Clinical CenterUG1HD040492 · NICHD · DUKE UNIVERSITY · PI CHARLES Michael COTTEN, Matthew Laughon · 2016 to 2026
$3.4M
NICHD Neonatal Research Network - Stanford UniversityUG1HD027880 · NICHD · STANFORD UNIVERSITY · PI Valerie Chock · 2016 to 2026
$3.3M
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemiaR01HD081044 · NICHD · DUKE UNIVERSITY · PI FISHER, BRIAN T, STEINBACH, WILLIAM J · 2014 to 2018
$3.2M
NICHD Cooperative Multicenter Neonatal Research NetworkUG1HD053109 · NICHD · UNIVERSITY OF IOWA · PI Tarah Trinity Colaizy · 2016 to 2026
$3.2M
NICHD Neonatal Research NetworkUG1HD027851 · NICHD · EMORY UNIVERSITY · PI Ravi Mangal Patel · 2016 to 2026
$3.0M
NICHD Neonatal Research NetworkUG1HD027904 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI MARON, JILL LAMANNA · 2016 to 2024
$2.1M
Multidisciplinary Neonatal Training GrantT32HD043728 · NICHD · DUKE UNIVERSITY · PI GOLDBERG, RONALD · 2005 to 2014
$1.3M
FDA HHS R18 FD005292NCATS NIH HHS UL1 TR001117NICHD NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003INICHD NIH HHS R01 HD081044NICHD NIH HHS T32 HD043728NICHD NIH HHS U10 HD040492NICHD NIH HHS UG1 HD027851NICHD NIH HHS UG1 HD027880NICHD NIH HHS UG1 HD027904NICHD NIH HHS UG1 HD040492NICHD NIH HHS UG1 HD053109
6 · The paper itself

Abstract

backgroundLate-onset sepsis (LOS) is an important cause of death and neurodevelopmental impairment in premature infants. The purpose of this study was to assess overall incidence of LOS, distribution of LOS-causative organisms and center variation in incidence of LOS for extremely premature infants over time.

methodsIn a retrospective analysis of infants 401-1000 g birth weight and 22-28 6/7 weeks of gestational age born at 12 National Institute of Child Health and Human Development Neonatal Research Network centers in the years 2000-2005 (era 1) or 2006-2011 (era 2) who survived >72 hours, we compared the incidence of LOS and pathogen distribution in the 2 eras using the χ test. We also examined the effect of birth year on the incidence of LOS using multivariable regression to adjust for nonmodifiable risk factors and for center. To assess whether the incidence of LOS was different among centers in era 2, we used a multivariable regression model to adjust for nonmodifiable risk factors.

resultsTen-thousand one-hundred thirty-one infants were studied. LOS occurred in 2083 of 5031 (41%) infants in era 1 and 1728 of 5100 (34%) infants in era 2 (P < 0.001). Birth year was a significant predictor of LOS on adjusted analysis, with birth years 2000-2009 having a significantly higher odds of LOS than the reference year 2011. Pathogens did not differ, with the exception of decreased fungal infection (P < 0.001). In era 2, 9 centers had significantly higher odds of LOS compared with the center with the lowest incidence.

conclusionsThe incidence of LOS decreased over time. Further investigation is warranted to determine which interventions have the greatest impact on infection rates.

Indexed as

Infant, Extremely PrematureFemaleHumansInfant, NewbornMaleNeonatal SepsisRetrospective StudiesUnited States

Identifiers

PMID28709162
PMCPMC5627954
OpenAlexW2589444564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.